Drug Shortage Report for DEPO-PROVERA
| Report ID | 131486 |
| Drug Identification Number | 00585092 |
| Brand name | DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML |
| Common or Proper name | DEPO-PROVERA |
| Company Name | PFIZER CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | MEDROXYPROGESTERONE ACETATE |
| Strength(s) | 150MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1 x 1ML |
| ATC code | G03AC |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-07-23 |
| Actual start date | 2021-07-21 |
| Estimated end date | 2023-06-01 |
| Actual end date | 2022-08-05 |
| Shortage status | Resolved |
| Updated date | 2022-12-20 |
| Company comments | Product discontinued, see posting 178953. Other presentation available, pre-filled syringes (DIN 02523493) |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.